Muzaffar H. Qazilbash, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Muzaffar H. Qazilbash, MD

Muzaffar H. Qazilbash, MD

Healthcare Professional
Director
Myeloma Transplantation
and Cellular Therapy
MD Anderson Cancer Center
University of Texas
1515 Holcombe Blvd.
Houston, Texas, United States
Muzaffar Qazilbash is a Professor of medicine and Director of myeloma transplantation and cellular therapy in the Department of Stem Cell Transplantation at The University of Texas MD Anderson Cancer Center. He is a non resident scholar for biomedical research policy in the Center for Health and Biosciences. 
 
Qazilbash obtained his medical degree from the University of Karachi, Pakistan. He was trained in internal medicine at the University of Connecticut and in hematology and oncology at the National Institute of Health in Bethesda, Maryland.
 
Qazilbash’s research focuses on the development of novel therapies for stem cell transplantation and immunotherapy for patients with multiple myeloma, a common blood cancer. He has successfully taken cancer vaccines from basic science laboratories to clinical trials for patients with blood cancers. His research also focuses on improving the safety and effectiveness of stem cell transplants for patients with blood cancers. Qazilbash has authored or co-authored more than 175 peer-reviewed articles in medical journals and is a member of several professional societies, and takes keen interest in health policy and its impact on biomedical research. He is also a practicing hematologist at the MD Anderson Cancer Center.
 
 
Representative Publications:
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close